亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購(gòu)物車
企業(yè)會(huì)員第1年

上海瀚鴻化工有限公司  

氨基酸 醫(yī)藥中間體 定制合成
搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人：楊召鵬
  • 電話：021-54280654
  • 郵件：kenny@hanhonggroup.com
  • 傳真：021-54291107
  • QQ：380387453
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > (S)-4-苯基-2-惡唑烷酮 cas號(hào)99395-88-7
(S)-4-苯基-2-惡唑烷酮 cas號(hào)99395-88-7
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 上海付款后3天內(nèi)
品牌 國(guó)產(chǎn)品牌
過期 長(zhǎng)期有效
更新 2020-06-04 17:00
 
詳細(xì)信息
(S)-(+)-4-Phenyl-2-oxazolidinone
(S)-4-苯基-2-惡唑烷酮 cas號(hào)99395-88-7
用途 依折麥布 Ezetimibe

聯(lián)系人：楊召鵬    電話 021-54280654   手機(jī) 13761555910（微信同號(hào)）  QQ 2355241785

©2025 上海瀚鴻化工有限公司 版權(quán)所有   技術(shù)支持：化工網(wǎng)   訪問量:6161  
 
主站蜘蛛池模板： | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |